HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Abstract
Authors
Maria Manuel Teixeira Diogo Manuel Monteiro Fábio Cardoso Borges Bruno Sepodes Madeline Pe Carla Torre